Cargando…

Development of a bead-based Luminex assay using lipopolysaccharide specific monoclonal antibodies to detect biological threats from Brucella species

BACKGROUND: Brucella, a Gram-negative bacterium, is classified as a potential bioterrorism agent mainly due to the low dose needed to cause infection and the ability to transmit the bacteria via aerosols. Goats/sheep, cattle, pigs, dogs, sheep and rodents are infected by B. melitensis, B. abortus, B...

Descripción completa

Detalles Bibliográficos
Autores principales: Silbereisen, Angelika, Tamborrini, Marco, Wittwer, Matthias, Schürch, Nadia, Pluschke, Gerd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595103/
https://www.ncbi.nlm.nih.gov/pubmed/26438077
http://dx.doi.org/10.1186/s12866-015-0534-1
_version_ 1782393537933869056
author Silbereisen, Angelika
Tamborrini, Marco
Wittwer, Matthias
Schürch, Nadia
Pluschke, Gerd
author_facet Silbereisen, Angelika
Tamborrini, Marco
Wittwer, Matthias
Schürch, Nadia
Pluschke, Gerd
author_sort Silbereisen, Angelika
collection PubMed
description BACKGROUND: Brucella, a Gram-negative bacterium, is classified as a potential bioterrorism agent mainly due to the low dose needed to cause infection and the ability to transmit the bacteria via aerosols. Goats/sheep, cattle, pigs, dogs, sheep and rodents are infected by B. melitensis, B. abortus, B. suis, B. canis, B. ovis and B. neotomae, respectively, the six classical Brucella species. Most human cases are caused by B. melitensis and B. abortus. Our aim was to specifically detect Brucellae with ‘smooth’ lipopolysaccharide (LPS) using a highly sensitive monoclonal antibody (mAb) based immunological assay. METHODS: To complement molecular detection systems for potential bioterror agents, as required by international biodefense regulations, sets of mAbs were generated by B cell hybridoma technology and used to develop immunological assays. The combination of mAbs most suitable for an antigen capture assay format was identified and an immunoassay using the Luminex xMAP technology was developed. RESULTS: MAbs specific for the LPS O-antigen of Brucella spp. were generated by immunising mice with inactivated B. melitensis or B. abortus cells. Most mAbs recognised both B. melitensis and B. abortus and antigen binding was not impeded by inactivation of the bacterial cells by γ irradiation, formalin or heat treatment, a step required to analyse the samples immunologically under biosafety level two conditions. The Luminex assay recognised all tested Brucella species with ‘smooth’ LPS with detection limits of 2 × 10(2) to 8 × 10(4) cells per mL, depending on the species tested. Milk samples spiked with Brucella spp. cells were identified successfully using the Luminex assay. In addition, the bead-based immunoassay was integrated into a multiplex format, allowing for simultaneous, rapid and specific detection of Brucella spp., Bacillus anthracis, Francisella tularensis and Yersinia pestis within a single sample. CONCLUSION: Overall, the robust Luminex assay should allow detection of Brucella spp. in both natural outbreak and bio-threat situations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12866-015-0534-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4595103
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45951032015-10-07 Development of a bead-based Luminex assay using lipopolysaccharide specific monoclonal antibodies to detect biological threats from Brucella species Silbereisen, Angelika Tamborrini, Marco Wittwer, Matthias Schürch, Nadia Pluschke, Gerd BMC Microbiol Research Article BACKGROUND: Brucella, a Gram-negative bacterium, is classified as a potential bioterrorism agent mainly due to the low dose needed to cause infection and the ability to transmit the bacteria via aerosols. Goats/sheep, cattle, pigs, dogs, sheep and rodents are infected by B. melitensis, B. abortus, B. suis, B. canis, B. ovis and B. neotomae, respectively, the six classical Brucella species. Most human cases are caused by B. melitensis and B. abortus. Our aim was to specifically detect Brucellae with ‘smooth’ lipopolysaccharide (LPS) using a highly sensitive monoclonal antibody (mAb) based immunological assay. METHODS: To complement molecular detection systems for potential bioterror agents, as required by international biodefense regulations, sets of mAbs were generated by B cell hybridoma technology and used to develop immunological assays. The combination of mAbs most suitable for an antigen capture assay format was identified and an immunoassay using the Luminex xMAP technology was developed. RESULTS: MAbs specific for the LPS O-antigen of Brucella spp. were generated by immunising mice with inactivated B. melitensis or B. abortus cells. Most mAbs recognised both B. melitensis and B. abortus and antigen binding was not impeded by inactivation of the bacterial cells by γ irradiation, formalin or heat treatment, a step required to analyse the samples immunologically under biosafety level two conditions. The Luminex assay recognised all tested Brucella species with ‘smooth’ LPS with detection limits of 2 × 10(2) to 8 × 10(4) cells per mL, depending on the species tested. Milk samples spiked with Brucella spp. cells were identified successfully using the Luminex assay. In addition, the bead-based immunoassay was integrated into a multiplex format, allowing for simultaneous, rapid and specific detection of Brucella spp., Bacillus anthracis, Francisella tularensis and Yersinia pestis within a single sample. CONCLUSION: Overall, the robust Luminex assay should allow detection of Brucella spp. in both natural outbreak and bio-threat situations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12866-015-0534-1) contains supplementary material, which is available to authorized users. BioMed Central 2015-10-05 /pmc/articles/PMC4595103/ /pubmed/26438077 http://dx.doi.org/10.1186/s12866-015-0534-1 Text en © Silbereisen et al. 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Silbereisen, Angelika
Tamborrini, Marco
Wittwer, Matthias
Schürch, Nadia
Pluschke, Gerd
Development of a bead-based Luminex assay using lipopolysaccharide specific monoclonal antibodies to detect biological threats from Brucella species
title Development of a bead-based Luminex assay using lipopolysaccharide specific monoclonal antibodies to detect biological threats from Brucella species
title_full Development of a bead-based Luminex assay using lipopolysaccharide specific monoclonal antibodies to detect biological threats from Brucella species
title_fullStr Development of a bead-based Luminex assay using lipopolysaccharide specific monoclonal antibodies to detect biological threats from Brucella species
title_full_unstemmed Development of a bead-based Luminex assay using lipopolysaccharide specific monoclonal antibodies to detect biological threats from Brucella species
title_short Development of a bead-based Luminex assay using lipopolysaccharide specific monoclonal antibodies to detect biological threats from Brucella species
title_sort development of a bead-based luminex assay using lipopolysaccharide specific monoclonal antibodies to detect biological threats from brucella species
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595103/
https://www.ncbi.nlm.nih.gov/pubmed/26438077
http://dx.doi.org/10.1186/s12866-015-0534-1
work_keys_str_mv AT silbereisenangelika developmentofabeadbasedluminexassayusinglipopolysaccharidespecificmonoclonalantibodiestodetectbiologicalthreatsfrombrucellaspecies
AT tamborrinimarco developmentofabeadbasedluminexassayusinglipopolysaccharidespecificmonoclonalantibodiestodetectbiologicalthreatsfrombrucellaspecies
AT wittwermatthias developmentofabeadbasedluminexassayusinglipopolysaccharidespecificmonoclonalantibodiestodetectbiologicalthreatsfrombrucellaspecies
AT schurchnadia developmentofabeadbasedluminexassayusinglipopolysaccharidespecificmonoclonalantibodiestodetectbiologicalthreatsfrombrucellaspecies
AT pluschkegerd developmentofabeadbasedluminexassayusinglipopolysaccharidespecificmonoclonalantibodiestodetectbiologicalthreatsfrombrucellaspecies